Adam J Sullivan

Today at 1:00 p.m. ET, Capricor and @PPMD are hosting a webinar on the latest HOPE-3 open-label extension 2-year results, presented last week at the World Muscle Society Congress in Japan. We will walk through the data in more detail and discuss what these results may mean for the Duchenne muscular dystrophy community. Register here: bit.ly/3Ubm3c8 $CAPR #Deramiocel #PPMD #Duchenne #DMD

Capricor today announced new 24-month data from the HOPE-3 open-label extension, presented last week in a late-breaking poster at the 2026 World Muscle Society Congress in Hiroshima, Japan. Patients who began Deramiocel after a year on placebo experienced a 76% reduction in their rate of upper limb decline compared with their own prior year. At 24 months, both treatment groups had declined less than natural history predicts. Read the full press release: bit.ly/4ANTtOD #Duchenne #DMD #WMS2026 #Deramiocel $CAPR

Capricor is headed to the 2026 World Muscle Society Congress in Hiroshima, Japan, September 29 – October 3. We’re looking forward to sharing new HOPE-3 open-label extension data for Deramiocel in Duchenne muscular dystrophy, including skeletal muscle and cardiac outcomes through 24 months. Dr. Craig McDonald of UC Davis will present the findings in a late-breaking poster and an oral presentation, alongside additional research from our StealthX™ platform exploring muscle-targeting extracellular vesicle technologies. We’re proud to continue advancing the science and working toward better options for boys and families living with Duchenne. 💙 Read more: bit.ly/3TFiBWZ $CAPR #Deramiocel #Duchenne #DMD #exosomes #WMS2026 #WorldMuscleSociety

Today, we join the global community in recognizing World Duchenne Awareness Day. This year’s theme, “Access Changes Lives,” reminds us that meaningful progress goes beyond just scientific breakthroughs. It means ensuring that individuals living with Duchenne and Becker muscular dystrophy have access to the care, support, and opportunities they need. At Capricor, we remain committed to continuing to push forward with Deramiocel and our mission to help make a difference in the lives of those living with DMD. Together, we can raise awareness, inspire action, and work toward a brighter future for the Duchenne community. 💚 $CAPR #WDAD2026 #DuchenneAwareness #DMD #AccessChangesLives #Deramiocel

Capricor has shared its comments regarding the FDA briefing materials in advance of the upcoming July 29 FDA Advisory Committee Meeting for Deramiocel. $CAPR #deramiocel #DMD Click the link below to read the press release.>>> bit.ly/4vRqq96